Mavoglurant developmental code name AFQ-056 is an experimental drug candidate for the treatment of fragile X syndrome. Reference standards of Mavoglurant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Mavoglurant - API Standards [catalogue_number] => PA 13 3110000 [category_ids] => ,79,71,78,70,82,75, [chemical_name] => [weight] => 313.4 [form] => C19H23NO3 [cas] => 543906-09-8 [pslug] => 543906-09-8-mavoglurant-api-standards-pa133110000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 13 3110000
CAS :
Molecular Formula : C19H23NO3
Molecular Weight : 313.4
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....